Generics - Pharmaceutical, Anti-virals

Filter

Current filters:

PharmaceuticalAnti-virals

Popular Filters

Brazil to produce atazanavir to supply SUS demand; strong pharma growth forecast for 2014

15-01-2014

Following the Official Gazette market application filling for the drug atazanavir sulfate, an HIV protease…

Anti-viralsatazanavirBrazilBristol-Myers SquibbFiocruzGenericsMarkets & MarketingPharmaceuticalProductionSouth America

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products

30-05-2013

UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Pilot project for HIV/AIDS drug management supported by PAHO/WHO and the Global Fund may expand to other countries

07-04-2013

Three Latin American countries - Guatemala, Honduras, and the Dominican Republic - are working to strengthen…

Anti-viralsGenericsHealthcareManagementPharmaceuticalSouth America

Medicines Patent Pool and ViiV Healthcare collaborate to treat pediatric HIV

28-02-2013

The Medicines Patent Pool (MPP) this week announced the launch of a new collaboration with ViiV Healthcare…

AbacavirAnti-viralsGenericsGlobalPatentsPharmaceuticalViiV Healthcare

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices

16-01-2013

A new study published in the Annals of Internal Medicine that provides a snapshot of a simplified cost/benefit…

Anti-viralsAtriplaGenericsGilead SciencesNorth AmericaPharmaceuticalPricingStribild

Sales of antiretroviral agents for HIV will decline slightly over next decade

18-12-2012

Major-market sales of antiretroviral (ARV) agents for HIV will decline slightly over the next decade,…

Anti-viralsBiotechnologydolutegravirGenericsGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRegulationViiV Healthcare

Indonesian government overrides patents on seven HIV and hepatitis drugs

15-10-2012

In a move that was announced in early September but which just came to light last week, the government…

Anti-viralsGenericsPatentsPharmaceuticalPoliticsPricing

Consumer groups call for fixed-dose HIV drugs in South African tenders

16-08-2012

Consumer groups Treatment Action Campaign and Medecins sans Frontiers have issued a call for the inclusion…

Anti-viralsGenericsHealthcareMarkets & MarketingPharmaceuticalPricingRest of the World

Middle-income countries flex muscles to overcome patents in face of unaffordable drug prices

29-07-2012

Middle-income countries are increasingly taking measures to overcome the patents that price drugs out…

Anti-viralsGenericsGlobalPatentsPharmaceuticalPricing

More than 150 ARVs available through PEPFAR for global HIV/AIDS relief

24-07-2012

US Food and Drug Administration Commissioner Margaret Hamburg says that the agency has approved or tentatively…

Anti-viralsGenericsGlobalPharmaceuticalRegulation

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

24-07-2012

Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases…

Anti-viralsCiplaGenericsGlobalPharmaceuticalResearch

Antivirals market facing generics threat, especially for HIV drugs

03-07-2012

Generic copies of branded drugs are predicted to take over the antiviral drugs market, especially in…

Anti-viralsGenericsMarkets & MarketingPatentsPharmaceutical

FDA delays once-a-day Prezista approval; finds counterfeit of Teva's Adderall

30-05-2012

US health care giant Johnson & Johnson's (NYSE: JNJ) Janssen Therapeutics division has received a complete…

AdderallAnti-viralsGenericsJanssenJohnson & JohnsonMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalPrezistaRegulationTeva Pharmaceutical Industries

Tanzanian drugmaker to start producing ARVs in August

23-05-2012

Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

COMPANY SPOTLIGHT

Menarini

Back to top